Using technology to treat sleep apnea in people with prediabetes
Technology-Supported Treatment of Sleep Apnea in Prediabetes
This study is looking at how using technology to treat sleep apnea can help people with prediabetes feel better and stay healthier, by testing methods like CPAP therapy and lifestyle changes such as diet and exercise.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10886362 on NIH RePORTER |
What this research studies
This research investigates the use of technology-supported treatments for sleep apnea in individuals with prediabetes. It aims to identify and treat sleep apnea, which is often undiagnosed in this population, to improve their overall health outcomes. The study will explore the effectiveness of continuous positive airway pressure (CPAP) therapy and lifestyle interventions, such as diet and exercise, in reducing the risk of diabetes and cardiovascular complications. By focusing on this high-risk group, the research seeks to provide evidence that could lead to better screening and treatment practices.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with prediabetes who may also have undiagnosed sleep apnea.
Not a fit: Patients without prediabetes or those who do not have sleep apnea may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention strategies for diabetes and reduced cardiovascular risks in patients with prediabetes.
How similar studies have performed: While there has been significant research on lifestyle interventions for prediabetes, this specific approach of integrating sleep apnea treatment with technology support is novel and has not been extensively tested.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Tasali, Esra — University of Chicago
- Study coordinator: Tasali, Esra
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.